Deal title |
Principal company |
Partner company |
Total projected at signing (US$M) |
Technologies |
Date announced |
Ravenquest acquires a majority stake in Alberta Green Biotech |
Alberta Green Biotech Inc. |
Ravenquest Biomed Inc. |
Payment Unspecified |
Small-molecule therapeutic |
5/25/17 |
KBI to acquire Alliance Protein Laboratories |
Alliance Protein Laboratories |
KBI Biopharma Inc. |
Payment Unspecified |
Biosimilar product; gene transfer system; monoclonal antibody; peptide |
6/15/17 |
Nantcell to acquire Altor Bioscience |
Altor Bioscience Corp. |
Nantcell Inc. |
Payment Unspecified |
Small-molecule therapeutic |
6/27/17 |
Aviragen to merge with Vaxart |
Aviragen Therapeutics Inc. |
Vaxart Inc. |
$1.75 |
Small-molecule therapeutic |
10/27/17 |
Creat Group to acquire Biotest |
Biotest AG |
Creat Group Corp. |
$1,300.00 |
Small-molecule therapeutic |
3/29/17 |
CSL Behring to acquire Calimmune |
Calimmune Inc. |
CSL Ltd. |
$416.00 |
Stem cell therapy; |
8/28/17 |
Protext Mobility acquires Cannabis Biosciences |
Cannabis Biosciences Inc. |
Protext Mobility Inc. |
Payment Unspecified |
Small-molecule therapeutic |
3/27/17 |
Sevion to acquire Eloxx Pharmaceuticals |
Eloxx Pharmaceuticals Ltd. |
Sevion Therapeutics Inc. |
Payment Unspecified |
Small-molecule therapeutic |
5/31/17 |
Nulife to sign letter of intent to acquire Ensysce Biosciences |
Ensysce Biosciences Inc. |
Nulife Sciences Inc. |
Payment Unspecified |
Small-molecule therapeutic |
10/25/17 |
Espero and Armetheon to merge to form a new company Espero Biopharma |
Espero Biopharma Inc. |
Armetheon Inc. |
Payment Unspecified |
Small-molecule therapeutic |
3/30/17 |
Neothetics to merge with Evofem |
Evofem Biosciences |
Neothetics Inc. |
Payment Unspecified |
Small-molecule therapeutic |
10/17/17 |
Nupharm to acquire FB Health |
FB Health |
Nupharm Italy SpA |
Payment Unspecified |
Small-molecule therapeutic |
6/19/17 |
Winston entered into letter of intent to acquire GT Therapeutics |
Green Tree Therapeutics LLC |
Winston Resources LLC |
$25.12 |
Small-molecule therapeutic |
2/24/17 |
Dance Biopharm to purchase Harmony Biopharm |
Harmony Biopharm Ltd. |
Dance Biopharm Inc. |
Payment Unspecified |
Protein recombinant |
8/29/17 |
Kangen Pharmaceuticals to acquire KC Specialty Therapeutics |
KC Specialty Therapeutics LLC |
Kangen Pharmaceuticals Co. Ltd. |
Payment Unspecified |
Small-molecule therapeutic |
12/13/17 |
Gilead Sciences acquires Kite Pharma |
Kite Pharma Inc. |
Gilead Sciences Inc. |
$12,256.00 |
Cell therapy |
8/27/17 |
Ethypharm to acquire Martindale |
Martindale Pharma |
Ethypharm SA |
Payment Unspecified |
Small-molecule therapeutic |
1/19/17 |
Astellas to acquire Mitobridge |
Mitobridge Inc. |
Astellas Pharma Inc. |
$450.00 |
Small-molecule therapeutic |
11/30/17 |
Immunoprecise Antibodies entered into letter of intent to acquire Modiquest |
Modiquest BV |
Immunoprecise Antibodies Ltd. |
$8.23 |
Monoclonal antibody human |
12/7/17 |
Otsuka Pharmaceutical to acquire Neurovance |
Neurovance Inc. |
Otsuka Pharmaceutical Co. Ltd. |
$250.00 |
Small-molecule therapeutic |
3/2/17 |
Black Beret to acquire Okyanos |
Okyanos Operating Company Ltd. |
Black Beret Life Sciences LLC |
Payment Unspecified |
Stem cell therapy |
7/25/17 |
Hitachi Chemical acquires PCT |
PCT, a Caladrius |
Hitachi Chemical Co. America Ltd. |
$80.00 |
Biological therapeutic |
11/27/17 |
Skinvisible to enter a non-binding term sheet to merge with Quoin Pharmaceuticals |
Quoin Pharmaceuticals Ltd. |
Skinvisible Inc. |
Payment Unspecified |
Oligonucleotide |
9/6/17 |
Merck to acquire Rigontec |
Rigontec GmbH |
Merck & Co. Inc. |
$552.30 |
Small-molecule therapeutic |
7/24/17 |
Briacell to acquire Sapientia Pharmaceuticals |
Sapientia Pharmaceuticals Inc. |
Briacell Therapeutics Corp. |
Payment Unspecified |
Generic product; biosimilar product |
5/11/17 |
Nidda Healthcare to acquire Stada Arzneimittel |
Stada Arzneimittel AG |
Nidda Healthcare Holding AG |
Payment Unspecified |
Oligonucleotide; biological therapeutic; immuno-oncology |
11/1/17 |
Mitsubishi Tanabe to acquire Stelic Institute |
Stelic Institute & Co. |
Mitsubishi Tanabe Pharma Corp. |
$104.79 |
Small-molecule therapeutic |
10/11/17 |
Lupin acquires Symbiomix Therapeutics |
Symbiomix Therapeutics LLC |
Lupin Pharmaceuticals Inc. |
Unknown |
Oligonucleotide |
1/9/17 |
Fountain Biopharma to merge with Synovel Sciences |
Synovel Sciences Inc. |
Fountain Biopharma Inc. |
Payment Unspecified |
Chimeric monoclonal |
3/16/17 |
Notes Source: Cortellis Deals Intelligence * This chart includes pending mergers and acquisitions announced within the past year. |